Arthur Daemmrich is the Jerome and Dorothy Lemelson Director of the Lemelson Center for the Study of Invention and Innovation at the Smithsonian Institution. Located in the National Museum of American History, the Lemelson Center carries out historical research into invention and innovation, develops educational programs to inspire the next generation of inventors, and creates exhibits that engage some 4.5 million museum visitors annually.
Daemmrich’s scholarly work analyzes the emergence of technology-based industries, explores the relationship between regulation and innovation, and compares innovation systems internationally. He is the author of Pharmacopolitics: Drug Regulation in the United States and Germany and has published over 50 peer-reviewed journal articles, book chapters, and teaching cases in science and technology studies; the history of science, technology, and medicine; and health and business policy.
Before coming to the Lemelson Center, Daemmrich was an associate professor at the University of Kansas School of Medicine, an assistant professor at Harvard Business School, a visiting professor at the China Europe International Business School, and a research fellow and director of contemporary history at the Chemical Heritage Foundation. He holds a PhD from Cornell University in Science and Technology Studies and a BA from the University of Pennsylvania in the History and Sociology of Science.
